Diabetes, Endocrinology & Metabolism

Dr. Jan Polak obtained PhD in the year 2007 from Charles University in Prague, Czech Republic. He was appointed as the head of department for the study of Obesity and Diabetes, Charles University in Prague in the year 2017. He is an editorial board member of Diabetology, Metabolism, Endocrinology and Nutrition and associate editor of Frontiers in Endocrinology. He has around 62 publications in reputed and peer-reviewed journals.

Diabetes, Endocrinology, Obesity

Dr. Chan Jong Kim has been Graduated from Medical School of Chonnam National University as Medical Doctor, with the specialty including Pediatric Endocrinology and Metabolism. Presently he has been working at the Gwangju City.

type 1 diabetes, diabetic ketoacidosis, acute kidney injury, children

Dr Veronique Michaud received her Bachelor degree in Pharmacy in 2001 from Laval University, Quebec City and earned her Ph.D. and M.Sc. degrees from the Université de Montréal, Montreal, Canada. She completed fellowship at McGill’s AIDS Centre, Lady Davis Institute, McGill University, Montreal (2009-2010). She undertook a second fellowship in the department of Clinical Pharmacology, School of medicine, Indiana University, Indianapolis (2010-2012). Dr Michaud joined the University of Florida College of Pharmacy as an associate professor of pharmacotherapy and translational research in January 2018. Prior to joining the UF College of Pharmacy, Michaud served as the vice president of scientific affairs at TabulaRasa Health Care in New Jersey. She was an assistant professor, Faculty of pharmacy, Université de Montréal from 2012 to 2016.

Her research interests focus on identifying factors responsible for intersubject variability in drug response. Her search investigates the contribution of CYP450 drug-metabolizing enzymes in drug disposition, with a special attention to the role of disease state, focusing on type 2 diabetes (T2D) in a CYP450 isozyme-selective and a tissue-selective fashion. One of the major focus of her research is to study of intracellular drug-metabolism leading to modulation of drug action or side effects as well as the role of pharmacogenomics and drug-drug interactions.

Dr Ana Pokrajac MD MSc FRCP ​ Dr Pokrajac graduated Cum Laude from the University of Belgrade, School of Medicine, in Jan 2000 and upon graduation she was awarded a training post with the University. She was doing research in parallel with the clinical duties and presented in national and international conferences. Dr Pokrajac holds an MSc in Endocrinology (2003) and her particular focus at the time was Adrenal Insufficiency. She joined an award winning Endocrine Team at the Christie in Manchester in 2003, where she completed her Medical Doctorate on the relationship between GH and IGF-I and metabolic factors affecting it. As a Research Fellow, she took part in international research projects in Acromegaly, GH deficiency and Cushing’s Syndrome. Dr Pokrajac completed her specialty training (dual accreditation in Diabetes and Endocrinology and General Internal Medicine) with the North Western Deanery in 2012. Dr Pokrajac was appointed as a consultant in Diabetes, Endocrinology and GIM with West Herts Hospitals NHS Trust in 2012 where she practices and she is a Herts Valley CCG Lead for Diabetes and Chronic Kidney Disease. She has a special interest in complex diabetes, multimorbidity and evidence-based outcomes, but also in health-care system performance and cost-efficiency. She teaches medical students and is a RCP accredited educational supervisor to junior doctors.

Improvement of management and performance in the NHS Complex co-morbidities and diabetes Diabetes and Chronic Kidney Disease Digital Technology in Diabetes and medicine Support of self-management of long-term conditions